Melania P.

Melania P. is an experienced financial and business leader in the pharmaceutical sector, currently serving as a Board Member at Pro Generika since July 2024 and as VP of STADA Generics Germany and Managing Director of ALIUD PHARMA since September 2023. With a robust history at Novartis spanning from January 2010 to August 2023, Melania held several senior roles, including Business Unit Sr Director for Sandoz UK, CFO for UK & Ireland, and Chief Financial Officer for Novartis' chemical operations site, showcasing expertise in P&L management, innovative medicine launches, and biosimilars. Melania has strong academic foundations with an MScBA in Finance and a Bachelor's degree in International Business from the University of Ljubljana, complemented by studies at Linköping University.